Answers are grounded in this paper and cite their sources.
Thus, NAT-SLNs represent a promising ocular delivery system for treatment of deep corneal keratitis.
No takes yet. Share an insight, caveat, or question.
Khames et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: